Prelude Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Prelude Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell
2021 Q2	$3.44M	Buy
2020 Q4	–	Sell
2020 Q3	$4K	Buy
2019 Q2	–	Sell
2019 Q1	$454K	Buy